Resmed (RSMDF) Assets (2010 - 2026)

Resmed has reported Assets for 17 years, with the latest figure at $8.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 16.09% year-over-year to $8.8 billion; the trailing twelve-month figure through Mar 2026 stood at $8.8 billion (up 16.09% YoY), and the FY2025 full-year result was $8.2 billion, up 18.95% from the prior year.
• Assets for Q1 2026 stood at $8.8 billion, up from $8.5 billion in the prior quarter.
• The five-year high for Assets was $8.8 billion in Q1 2026, with the low at $4.9 billion in Q1 2022.
• Historically, Assets has averaged $7.0 billion across 5 years, with a median of $6.9 billion in 2024.
• Annual changes were most pronounced in 2022 — Assets soared 41.0% — and 2024, when it gained 1.5%.
• Resmed's Assets stood at $6.7 billion in 2022, then gained by 3.43% to $6.9 billion in 2023, then gained by 3.42% to $7.1 billion in 2024, then rose by 19.07% to $8.5 billion in 2025, then rose by 3.3% to $8.8 billion in 2026.
• The last three Assets figures came in at $8.8 billion (Q1 2026), $8.5 billion (Q4 2025), and $8.3 billion (Q3 2025), per Business Quant data.